Veramix Sponges 60 mg Sponge is a Health Canada–registered veterinary drug (DIN 00813583) held by Pharmacia Animal Health, containing Medroxyprogesterone Acetate. Health Canada lists its status as Cancelled Post Market (status date 02 Aug 2010). Nexara Health has matched 294 registrations of Medroxyprogesterone Acetate across 27 other regulated markets. A Canadian shortage record is open for this DIN.

Health Canada registration

Canadian shortage status

Health Canada shortage reporting lists this DIN as active (updated 2026-09-11). Reported reason: 100MG. Estimated resolution: . See the shortage pulse page for the timeline and marketed alternatives. Source: Drug Shortages Canada.

Medroxyprogesterone Acetate registered in other markets

294 registrations of the same molecule in 27 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Medroxyprogesterone Acetate worldwide →

Regulator price references for Medroxyprogesterone Acetate

Published list or reimbursement prices for Medroxyprogesterone Acetate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Veramix Sponges (DIN 00813583) marketed in Canada?

No. Health Canada lists DIN 00813583 as Cancelled Post Market as of 02 Aug 2010.

Who holds the Canadian licence for this product?

Pharmacia Animal Health is the company of record in the Health Canada Drug Product Database.

Is Medroxyprogesterone Acetate registered outside Canada?

Yes — Nexara Health has matched 294 registrations in 27 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00813583, status date 2010-08-02; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA; Drug Shortages Canada (drugshortagescanada.ca). Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00813583, status date 2010-08-02; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA; Drug Shortages Canada (drugshortagescanada.ca).

Health Canada Drug Product Database (DPD), DIN 00813583, status date 2010-08-02; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA; Drug Shortages Canada (drugshortagescanada.ca). Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.